HMGB1 and temporal lobe epilepsy: The anti‐seizure effect of the anti‐HMGB1 monoclonal antibody has been shown to have sufficient potential to treat seizures in both the kainic acid model and in tissue slices from patients with medically refractory temporal lobe epilepsy.45